Impact of time﹐fヾay atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study

Post time 6 day(s) ago

journal：Hepatology Research

Authors：Atsushi Naganuma; Satoru Kakizaki; Takeshi Hatanaka; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hidenori Toyoda; Yuichi Koshiyama; Chikara Ogawa; Hiroki Nishikawa; Takashi Nishimura; Kazuhito Kawata; Hisashi Kosaka; Kosuke Matsui; Yutaka Yata; Hironori Tanaka; Hideko Ohama; Hidekatsu Kuroda; Tomomitsu Matono; Tomoko Aoki; Hironori Ochi; Michitaka Imai; Shinichiro Nakamura; Yuki Kanayama; Kazunari Tanaka; Fujimasa Tada; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Hirayuki Enomoto; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada;

Published date：2025-5-

DOI：10.1111/hepr.14171

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hepr.14171

Article link：https://doi.org/10.1111/hepr.14171

Article Source：Wiley。

Remark：

Post time 6 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Wiley] Impact of time﹐fヾay atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Wiley] Impact of time﹐fヾay atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Wiley] Impact of time﹐fヾay atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study